Manuscripts
Showing 1452 manuscripts.
Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding
Citation
Sean S Brummel, Taha E Taha, Konstantia Angelidou, Friday Saidi, Patience Atuhaire, Dingase Dula, Dhayendre Moodley, ALlen Matubu, Gift Chareka, Neetal Nevrekar, Tichaona Vhembo, Lee Fairlie, Gerhard Theron, Pendo Mlay, Kathleen George, Michael Basar, Nahida Chakhtoura, Renee Browning, Mary Glenn Fowler, Judith S Currier, IMPAACT 1077BF/FF PROMISE Study Team. Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding. Journal of Acquired Immune Deficiency Syndromes. 2021. 86: 450-454. PMID: 33273210Journal
Journal of Acquired Immune Deficiency Syndromes
Study
1077BF (Y)
Pharmacokinetics and safety of maraviroc in neonates
Citation
Julia Rosebush, Brookie Best, Ellen Chadwick, Kevin Butler, John Moye, Elizabeth Smith, Sarah Bradford, Christina Reding, Sisinyana Mathiba, Sherika Hanley, Mariam Aziz, James Homans, Edward Acosta, William Murtaugh, Manoli Vourvahis, Lynn Mcfadyen, Katy Hayward, Mark Mirochnick, Pearl Samson, IMPAACT 2007 Study Team. Pharmacokinetics and safety of maraviroc in neonates. AIDS. 2021. PMID: 33252481Journal
AIDS
Study
IMPAACT 2007 (Y)
Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s
Citation
Kristina M Brooks, Jeremiah D Momper, Mauricio Pinilla, Alice M Stek, Emily Barr, Adriana Weinberg, Jaime G Deville, Irma L Febo, Mikhaela Cielo, Kathleen George, Kayla Denson, Kittipong Rungruengthanakit, David E Shapiro, Elizabeth Smith, Nahida Chakhtoura, James F Rooney, Richard Haubrich, Espina Rowena, Edmund V Capparelli, Mark Mirochnick, Brookie M Best, IMPAACT P1026s Protocol Team. Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s. AIDS. 2021. 35: 407-417. PMID: 33252495Journal
AIDS
Study
P1026S (Y)
Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
Citation
Lynda Stranix-Chibanda, Camlin Tierney, Dorothy Sebikari , Jim Aizire, Sufia Dadabhai, Admire Zanga, Cynthia Mukwasi-Kahari, Tichaona Vhembo, Avy Violari, Gerard Theron, Dhayandre Moodley , Kathleen George, Bo Fan, Markus J Sommer, Renee Browning, Lynne M Mofenson, John Shepherd, Bryan Nelson, Mary Glenn Fowler, George K Siberry , PROMISE P1084s study team. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial. PLoS One. 2021. 16: e0246272. PMID: 33544759Journal
PLoS One
Study
P1084s (N)
Impact of tenofovir-containing triple antiretroviral therapy on bone mineral density in breastfeeding women living with HIV enrolled in a randomized clinical trial
Citation
L Stranix-Chibanda, C Teirney, D Sebikari, J Aizire, S Dadabhai, A Zanga, C Mukwasi-Kahari, T Vhembo, A Violari, G Theron, D Moodley, K George, B Fan, M Sommer, M Basar, R Browning, L Mofenson, J Shepherd, B Nelson, MG Fowler, G Siberry for the PROMISE P1084s Study Team. Impact of tenofovir-containing triple antiretroviral therapy on bone mineral density in breastfeeding women living with HIV enrolled in a randomized clinical trial. The Journal of the American Medical Association. 2021. PMID: PendingJournal
The Journal of the American Medical Association
Study
P1084s (Y)
Time to Treatment Disruption in Children on Initial Protease Inhibitor vs. Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
Citation
D Yin, C Ludema, S Cole, C Golin, W Miller, M Warshaw, R McKinney ; on behalf of the PENPACT-1 (PENTA 9 / PACTG 390) Study Team. Time to Treatment Disruption in Children on Initial Protease Inhibitor vs. Non-Nucleoside Reverse Transcriptase Inhibitor Regimens. AIDS. 2020. PMID: 33226999Journal
AIDS
African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus
Citation
Michael J. Boivin, Miriam Chernoff, Barbara Laughton, Bonnie Zimmer, Celeste Joyce, Linda Barlow-Mosha, Mutsa Bwakura-Dangarembizi, Mmule Ratswana, Lee Fairlie, Portia Kamthunzi, Katie McCarthy, Itziar Familiar-Lopez, Patrick Jean-Philippe, Joan Coetzee, Nasreen Abrahams, Hermien Gous, Avy Violari, Mark F. Cotton, Paul Palumbo, IMPAACT P1104s Study Team, Tichaona Vhembo, Mmule Ratswana, Lee Fairlie, Portia Kamthunzi, Katie McCarthy, Itziar Familiar-Lopez, Patrick Jean-Philippe, Joan Coetzee, Nasreen Abrahams, Hermien Gous, Avy Violari, Mark F. Cotton, Paul Palumbo, IMPAACT P1104s Study Team. African Multi-Site 2-Year Neuropsychological Study of School-Age Children Perinatally Infected, Exposed, and Unexposed to Human Immunodeficiency Virus. Lancet HIV. 2020. PMID: 31848582Journal
Lancet HIV
Study
P1104s (Y)
Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy
Citation
G Theron, S Brummel, L Fairlie, M Pinilla, K McCarthy, M Owor, L Chinula, B Makanani, A Violari, D Moodley, N Chakhtoura, R Browning, R Hoffman, MG Fowler for the PROMISE 1077BF/1077FF Teams. Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Clinical Infectious Diseases. 2020. ciaa805PMID: 32564058Journal
Clinical Infectious Diseases
Study
1077BF (N), 1077FF (N)
Alendronate improves bone mineral density in perinatally HIV-Infected children and adolescents with low bone mineral density for age.
Citation
DL Jacobson, JC Lindsey, C Gordon, R Hazra, H Spiegel, J Benson, GK Siberry, IMPAACT P1076 Study Team. Alendronate improves bone mineral density in perinatally HIV-Infected children and adolescents with low bone mineral density for age.. Clinical Infectious Diseases. 2020. 71: 1281-1288. PMID: 31573608Journal
Clinical Infectious Diseases
Study
P1076 (N)
Enrollment and Transition Challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network’s PROMISE Trial for Resource-Limited Regions
Citation
K Angelidou, MG Fowler, P Flynn, A Coletti, K McCarthy, R Browning, J McIntyre, S Brummel, D Shapiro, Camlin Tierney for the PROMISE study team. Enrollment and Transition Challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network’s PROMISE Trial for Resource-Limited Regions. Clinical Trials. 2020. 17: 437-447. PMID: 32191142Journal
Clinical Trials
Study
1077BF (N), 1077FF (N)